Richard Shute

2
Reputation, corporate and personal, is an intangible asset of immense value. Building a positive reputation can be time-consuming, costly and difficult. Having your reputation ruined can, contrarily, be horribly easy and take but a moment. That is why corporations the world over – pharmaceutical companies and healthcare organizations are no exceptions – spend a lot […]

Blockchain and corporate reputation: could distributed ledger technology help (re)build ...

 in blog  tagged blockchain / corporate reputation / healthcare by
When it comes to blockchain technology in R&D, clearly: “It’s All About The Data Sharing”! This is the main conclusion that has come out from a Pistoia Alliance assessment of blockchain applications in life sciences R&D managed by Richard Shute of Curlew Research for The Alliance. Over 75 scientists and developers from Big Pharma, informatics software […]

“It’s All About The Data Sharing!” Pistoia Alliance’s “Blockchain in ...

 in blog  tagged blockchain / data / healthcare / integrity / R&D / sharing by
Image from https://www.davidwolfe.com/medical-journal-studies-fake/ In a new article published on February 7 by Bio-IT World on potential use-cases and applications of blockchain, Richard Shute, Curlew Research Consultant, looks at how distributed ledger technology could be used to reduce the scourge of scientific data falsification.  In this extract Richard gives some background to the issue and hints at how […]

Scientific Data Doctoring: Could Blockchain Technology Help Stamp It Out?

 in blog  tagged blockchain / data / laboratory / Use-case by
There is no doubt that the interest and hype around blockchain, or distributed ledger technology (DLT), builds daily. The explosion of articles and books recently is testament to this. But what is a blockchain and how might distributed ledger technology impact healthcare, Pharma and R&D? In a new article on pages 52-57 of the Fall […]

Blockchain Technology in Drug Discovery: Use Cases in R&D.

 in blog  tagged blockchain / data / ELN / genomics / healthcare / Identity / privacy / Security by
Recently, Curlew Research was involved in a project with Collaborative Drug Discovery, CDD (@CDDVault), to explore the value and market potential for their new ontology-based informatics product BioAssay Express, BAE (www.bioassayexpress.com).  As part of that project we interviewed a number of senior informaticians and scientists from top 10 Pharma and biotech research organizations in the […]

Curlew Research Helping to Promote Assay Informatics

 in blog  tagged BAE / bioassay / informatics / ontology / text by
Here at Curlew Research we are very interested in the potential offered by blockchain, also known as distributed ledger technology (DLT), to advance, enhance and disrupt healthcare – from candidate drug discovery to the medicines supply chain.  One area that seems to us ripe for the marriage of DLT and healthcare is genomics – specifically […]

Curlew Research Partner, Encrypgen Interviewed By Forbes.com

 in blog  tagged blockchain / encrypgen / gene-chain / genomics by
4
We are delighted to announce that Curlew Research will be leading a conference workshop at BioIT World Expo on May 23rd 2017– “An Intro To Blockchain In Life Science“. Blockchain technology, also known as “distributed ledger technology” (DLT) is currently one of the hottest tech items around. Every day, blockchain is being touted as a […]

Curlew Research Leading Workshop On Blockchain at BioIT World Expo, ...

 in blog  tagged blockchain / ehr / genomics / healthcare by